Are You Overpaying For IBM Stock Versus Its Rivals?
Are You Overpaying For IBM Stock Versus Its Rivals? Trefis
Covered in this story
Analyst targets on IBM
- Morgan Stanley: $234 → $238 by Oct 2027 · Equal-Weight via MarketBeat
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 48 stories mentioning IBM, the earliest published 20 Jul 2026.
Summary aggregated from Trefis's public RSS feed. The full reporting belongs to Trefis — please read it on their site.